Bridgewater Associates LP Has $4.42 Million Position in Chemed Co. (NYSE:CHE)

Bridgewater Associates LP cut its stake in Chemed Co. (NYSE:CHE) by 59.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,349 shares of the company’s stock after selling 12,207 shares during the period. Bridgewater Associates LP owned approximately 0.06% of Chemed worth $4,423,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CHE. Ontario Teachers Pension Plan Board raised its stake in Chemed by 53.8% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 1,672 shares of the company’s stock valued at $886,000 after purchasing an additional 585 shares in the last quarter. XTX Topco Ltd raised its position in shares of Chemed by 85.8% in the 4th quarter. XTX Topco Ltd now owns 5,281 shares of the company’s stock valued at $2,798,000 after buying an additional 2,438 shares in the last quarter. Barclays PLC lifted its holdings in shares of Chemed by 20.2% during the 4th quarter. Barclays PLC now owns 11,778 shares of the company’s stock worth $6,240,000 after acquiring an additional 1,983 shares during the period. Synovus Financial Corp acquired a new stake in shares of Chemed during the 4th quarter worth approximately $654,000. Finally, Brogan Financial Inc. bought a new position in Chemed in the fourth quarter valued at approximately $210,000. 95.85% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada upped their price objective on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.32% of the stock is owned by corporate insiders.

Chemed Trading Down 0.1 %

Shares of Chemed stock opened at $580.52 on Friday. The firm has a market capitalization of $8.48 billion, a PE ratio of 29.33, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The firm’s 50 day moving average is $585.78 and its 200 day moving average is $567.83. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.